Below are 3 natural substitutes to Bydureon that can reduce body weight and control blood sugar levels. For best results it is possible to use in a stack – this means combining 2 or more products ...
AstraZeneca (NYSE: AZN) announced that the FDA has approved Bydureon (exenatide extended-release) for injectable suspension as an add-on therapy to basal insulin in adults with type 2 diabetes with ...
Both natural supplements above are alternatives to Byetta (Exenatide). Both can be used in combination (or stacked) for greater benefit. Both products are made by two different manufacturers and so ...
Wednesday, Vivani Medical Inc (NASDAQ:VANI) released preclinical data on weight loss effects for NPM-115, the company’s miniature, twice-yearly exenatide subdermal implant under development for ...
Exenatide is a generic prescription drug approved to help manage blood sugar levels in adults with type 2 diabetes. It’s not available in a brand-name version. Exenatide comes as a liquid solution ...
SAN DIEGO (Reuters) - Analysis of an earlier trial found a "clinically insignificant" link between changes in heart rhythms and use of Bydureon, a long-acting diabetes drug being developed by Amylin ...
The FINANCIAL — LISBON, Portugal, Sept. 12, 2011 — Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced new analyses from the DURATION-3 and -4 trials demonstrating ...
A small, nonmechanical, implanted device that continuously releases the glucagon-like peptide-1 (GLP-1) receptor agonist exenatide (Byetta, Bydureon) and designed for improving glucose control in ...
SAN DIEGO, June 24 (Reuters) - Analysis of an earlier trial found a "clinically insignificant" link between changes in heart rhythms and use of Bydureon, a long-acting diabetes drug being developed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results